Omixon Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 61

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $25M

Omixon General Information

Description

Developer of genetics and molecular diagnostic products intended to be used in transplantation. The company provides laboratory reagents and software to determine human leukocyte antigen (HLA) genotypes based on next-generation sequencing and also provides post-transplant monitoring, enabling clinical labs with diagnostic products to improve patient outcomes.

Contact Information

Website
www.omixon.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Kaposvár utca 14-18.
  • Budapest, 1117
  • Hungary
Primary Industry
Diagnostic Equipment
Other Industries
Outcome Management (Healthcare)
Biotechnology
Acquirer
Corporate Office
  • Kaposvár utca 14-18.
  • Budapest, 1117
  • Hungary

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Omixon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 16-Oct-2024 $25M Completed Generating Revenue
6. Secondary Transaction - Private Completed Generating Revenue
5. Later Stage VC 15-Dec-2016 Completed Generating Revenue
4. Early Stage VC 17-Nov-2015 Completed Generating Revenue
3. Early Stage VC 14-May-2014 Completed Generating Revenue
2. Grant 09-May-2014 $450.12 $1.73M Completed Startup
1. Early Stage VC (Series A) 31-May-2012 $1.73M $1.73M Completed Startup
To view Omixon’s complete valuation and funding history, request access »

Omixon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of genetics and molecular diagnostic products intended to be used in transplantation. The company provides lab
Diagnostic Equipment
Budapest, Hungary
61 As of 2024

Seattle, WA
 

Bromborough, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Omixon Competitors (16)

One of Omixon’s 16 competitors is RareCyte, a Venture Capital-Backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RareCyte Venture Capital-Backed Seattle, WA
MC Diagnostics Corporate Backed or Acquired Bromborough, United Kingdom
Devyser Diagnostics Formerly PE-Backed Arsta, Sweden
Lunaphore Formerly VC-backed Tolochenaz, Switzerland
Biocartis Venture Capital-Backed Mechelen, Belgium
You’re viewing 5 of 16 competitors. Get the full list »

Omixon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Omixon Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
Euroventures Venture Capital Minority
FastVentures Venture Capital Minority
Futuremed Health Care Products Corporation Minority
You’re viewing 5 of 10 investors. Get the full list »

Omixon FAQs

  • When was Omixon founded?

    Omixon was founded in 2011.

  • Where is Omixon headquartered?

    Omixon is headquartered in Budapest, Hungary.

  • What is the size of Omixon?

    Omixon has 61 total employees.

  • What industry is Omixon in?

    Omixon’s primary industry is Diagnostic Equipment.

  • Is Omixon a private or public company?

    Omixon is a Private company.

  • What is the current valuation of Omixon?

    The current valuation of Omixon is .

  • What is Omixon’s current revenue?

    The current revenue for Omixon is .

  • How much funding has Omixon raised over time?

    Omixon has raised $6.91M.

  • Who are Omixon’s investors?

    , , Euroventures, FastVentures, and Futuremed Health Care Products are 5 of 10 investors who have invested in Omixon.

  • Who are Omixon’s competitors?

    RareCyte, MC Diagnostics, Devyser Diagnostics, Lunaphore, and Biocartis are some of the 16 competitors of Omixon.

  • When was Omixon acquired?

    Omixon was acquired on 16-Oct-2024.

  • Who acquired Omixon?

    Omixon was acquired by Werfen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process